R-2HG directly diminishes the demethylase activity of FTO and, subsequently, increases the overall m6A level in R-2HG-sensitive AML cells, which destabilizes MYC and CEBPA transcripts. The gene discussed is MYC; the disease is acute myeloid leukemia.